Grace Therapeutics - 53 Year Dividend History | GRCE

Historical dividend payout and yield for Grace Therapeutics (GRCE) since 1971. The current TTM dividend payout for Grace Therapeutics (GRCE) as of November 19, 2024 is $0.00. The current dividend yield for Grace Therapeutics as of November 19, 2024 is 0.00%.
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.032B $0.000B
Grace Therapeutics Inc. is a late-stage biopharma company advancing GTx-104, its novel injectable formulation of nimodipine which addresses high unmet medical needs for a rare disease, aneurysmal subarachnoid hemorrhage. Grace Therapeutics Inc., formerly known as Acasti Pharma Inc., is based in Princeton, New Jersey.
Stock Name Country Market Cap PE Ratio